Sage’s Jonas becomes CEO of CBC-backed incubator ABio-X

Jeffrey Jonas became CEO at ABio-X Holdings Inc., a CBC Group-backed biotech incubator. Jonas joins from Sage Therapeutics Inc. (NASDAQ:SAGE), where as chief innovation officer he engineered the brain health product pipeline. He also served as CEO at Sage between 2013 and 2022. 

Patient Square Capital’s  Enavate Sciences hired Edd Fleming as EVP, commercialization. Fleming was senior partner at McKinsey & Co. for over 25 years. Enavate hopes to invest in mid-stage rounds alongside the venture firms that have helped create start-ups, taking positions in biotechs that already have institutional capital...